IMAX Balance Sheet Health
Financial Health criteria checks 4/6
IMAX has a total shareholder equity of $367.8M and total debt of $276.3M, which brings its debt-to-equity ratio to 75.1%. Its total assets and total liabilities are $847.6M and $479.8M respectively. IMAX's EBIT is $41.3M making its interest coverage ratio 7. It has cash and short-term investments of $104.5M.
Key information
75.1%
Debt to equity ratio
US$276.28m
Debt
Interest coverage ratio | 7x |
Cash | US$104.50m |
Equity | US$367.79m |
Total liabilities | US$479.78m |
Total assets | US$847.56m |
Recent financial health updates
Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly
Oct 31Is IMAX (NYSE:IMAX) A Risky Investment?
Jun 19IMAX (NYSE:IMAX) Is Carrying A Fair Bit Of Debt
Mar 13Is IMAX (NYSE:IMAX) A Risky Investment?
Nov 28Is IMAX (NYSE:IMAX) Using Too Much Debt?
Jul 28Does IMAX (NYSE:IMAX) Have A Healthy Balance Sheet?
Mar 29Recent updates
IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively
Dec 10IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate
Nov 23After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar
Nov 07Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly
Oct 31If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity
Oct 13IMAX Corporation: Undervalued Relative To Revenue Growth And Margin Expansion Potential
Oct 10When Should You Buy IMAX Corporation (NYSE:IMAX)?
Sep 30Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture
Aug 23IMAX Corporation: Upbeat Mid-Term Outlook After Great Q2 Signings
Jul 30Pinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now
Jul 26Is IMAX (NYSE:IMAX) A Risky Investment?
Jun 19Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?
May 22IMAX Corporation: Good Reasons To Be Bullish
Apr 08IMAX Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next
Mar 01When Should You Buy IMAX Corporation (NYSE:IMAX)?
Feb 15IMAX Corporation: Bull Case Has Merits, But I Am Not Interested
Jan 22IMAX Corporation: International Expansion Remains A Bright Spot
Nov 19Some Investors May Be Worried About IMAX's (NYSE:IMAX) Returns On Capital
Oct 13IMAX Appears Expensive After Post-Pandemic Appreciation
Oct 09IMAX Corporation Stock: Bullish Following A Blockbuster Summer
Aug 24Should You Think About Buying IMAX Corporation (NYSE:IMAX) Now?
Jul 31These Return Metrics Don't Make IMAX (NYSE:IMAX) Look Too Strong
Jul 14IMAX Corporation: Coming Back To Life
Jun 15Are Investors Undervaluing IMAX Corporation (NYSE:IMAX) By 31%?
Jun 07Is It Time To Consider Buying IMAX Corporation (NYSE:IMAX)?
Apr 03IMAX (NYSE:IMAX) Is Carrying A Fair Bit Of Debt
Mar 13IMAX Non-GAAP EPS of $0.19 misses by $0.03, revenue of $98M beats by $1.77M
Feb 22IMAX, Cinema XXI expand relationship with deal for ten new theatres in Indonesia
Feb 14IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively
Feb 06IMAX Corporation: All Eyes On China
Jan 30IMAX plans to add seven new locations in Japanese expansion
Jan 19IMAX China gets new key person
Dec 12Is IMAX (NYSE:IMAX) A Risky Investment?
Nov 28IMAX, AMC partner on six new Saudi Arabia theaters
Oct 27Capital Allocation Trends At IMAX (NYSE:IMAX) Aren't Ideal
Oct 17IMAX Corporation: Watch Recent Buyback Program Expansion And Acquisition
Oct 04IMAX acquires streaming technology firm SSIMWAVE in cash-and-stock deal
Sep 22IMAX doubles buyback plan to $400M
Sep 07Cineworld, IMAX enter expanded deal for upgraded and new locations
Aug 03Is IMAX (NYSE:IMAX) Using Too Much Debt?
Jul 28IMAX Is Recovering, Not Growing
Jul 21IMAX extends current share repurchase program
Jun 30IMAX (NYSE:IMAX) Will Be Looking To Turn Around Its Returns
Jun 27IMAX Corporation: Multiple Tailwinds
Jun 21Does IMAX (NYSE:IMAX) Have A Healthy Balance Sheet?
Mar 29Financial Position Analysis
Short Term Liabilities: IMAX's short term assets ($405.8M) exceed its short term liabilities ($122.5M).
Long Term Liabilities: IMAX's short term assets ($405.8M) exceed its long term liabilities ($357.3M).
Debt to Equity History and Analysis
Debt Level: IMAX's net debt to equity ratio (46.7%) is considered high.
Reducing Debt: IMAX's debt to equity ratio has increased from 2.9% to 75.1% over the past 5 years.
Debt Coverage: IMAX's debt is well covered by operating cash flow (22.9%).
Interest Coverage: IMAX's interest payments on its debt are well covered by EBIT (7x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/20 05:56 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
IMAX Corporation is covered by 30 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Marla Backer | Ascendiant Capital Markets LLC |
James Goss | Barrington Research Associates, Inc. |
Michael Hickey | Benchmark Company |